PhenX - Use of creatine growth hormone and steroids protocol 230801:-:Pt: Patient:-:PhenX

Preferred Label : PhenX - Use of creatine growth hormone and steroids protocol 230801:-:Pt: Patient:-:PhenX;

LOINC status : ACTIVE;

LOINC long common name : PhenX - Use of Creatine Growth Hormone and Steroids Protocol 230801;

LOINC short name : PhenX - Creatine GH steroids use proto;

LOINC description : This is a single-item, three-part measure taken from the Growing Up Today Study (GUTS) that assesses use and frequency of various products (e.g., creatine, growth hormone, steroids) to improve muscle mass or strength in the past year.;

Détails

Origin ID

94451-2;

UMLS CUI

C5241055;

Has component
- Creatine [LOINC component]
- PhenX - Use of Creatine Growth Hormone and Steroids Protocol 230801 [LOINC component]
Has method
- PhenX [LOINC method]
Has system
- Patient [LOINC System]
- ^Patient [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Panel of LOINC codes
- Frequency of DHEA, androstenedione, or human growth hormone used to improve muscle mass or strength in past Y:NRat:1Y:^Patient:Ord: [LOINC code]
- Frequency of anabolic steroids used to improve muscle mass or strength in past Y:NRat:1Y:^Patient:Ord: [LOINC code]
- Frequency of creatine used to improve muscle mass or strength in past Y:NRat:1Y:^Patient:Ord: [LOINC code]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients